including vancomycin-resistant Enterococci (VRE), such as Enterococcus faecium (E. faecium). VRE causes severe hospital-acquired infections like endocarditis and sepsis and has developed ...

The following is a summary of “Combination therapy versus monotherapy: retrospective analysis of antibiotic treatment of enterococcal endocarditis,” published in the January 2025 issue of Infectious ...

The Company is also continuing recruitment for its Phase I Pharmacokinetic study in endocarditis ... to AMR - Lancet 2024 (ESKAPEE pathogens: Enterococcus faecium, Staphylococcus aureus ...

Echocardiographic evaluation of vegetations is crucial in infective endocarditis (IE ... followed by streptococcal species (28.2%) and enterococcal species (12.4%). Negative blood culture was found in ...

V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has ...

Injection drug use is a relatively infrequent cause of endocarditis in this group of patients in more contemporary cohorts. All patients with suspected Gram-negative endocarditis should undergo ...

From the available data, vancomycin-induced neutropenia is most likely associated with prolonged exposure and generally occurs at least 20 days after initiation of treatment. Patients who receive ...